Periodic Reporting for period 3 - MYCure (Innovative cancer therapy through Myc inhibition: taking OMO-103 to market)

Cancer is a global challenge with 9 million (M) deaths annually and new cases projected to rise by 70% in the next 20 years. Hence, there is a clear need for more effective therapies. We have expanded the scope of the MYCure project, now focusing on the major contributors to...